Day: March 28, 2023

Ekso Bionics Reports Fourth Quarter and Year End 2022 Results

Written by Customer Service on March 28, 2023. Posted in Earnings Releases And Operating Results.

SAN RAFAEL, Calif., March 28, 2023 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended December 31, 2022. Recent Highlights and AccomplishmentsCompleted the acquisition of the Human Motion Control (“HMC”) business unit including the Indego® product line from Parker Hannifin Corporation Generated revenue of $12.9 million for the 2022 full year, an increase of 15% year-over-year Booked a total of 100 EksoHealth devices for the 2022 full year, including Indego bookings post-acquisition Strong cash position of $20.5 million as of December 31, 2022“With the successful acquisition of the Indego product line, FDA clearance of EksoNR for rehabilitation use in...

HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights

Written by Customer Service on March 28, 2023. Posted in Earnings Releases And Operating Results.

MIRAMAR, Fla., March 28, 2023 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation and age-related diseases, today reported financial results and recent business highlights for its fourth quarter ended December 31, 2022. Hing C. Wong, Ph.D., Founder and CEO of HCW Biologics, stated, “We had a productive year in 2022, and our cancer program met or exceeded key milestones. In the fall, a preliminary first-in-human clinical data readout was presented at the SITC annual conference by Dr. Melissa Geller, the principal investigator for the University of Minnesota (“UMN”) sponsored Phase 1 clinical trial to evaluate...

Progress Announces First Quarter 2023 Financial Results

Written by Customer Service on March 28, 2023. Posted in Earnings Releases And Operating Results.

Revenue and Earnings Per Share Exceed Guidance ARR surges to $569M; MarkLogic Integration Underway BURLINGTON, Mass., March 28, 2023 (GLOBE NEWSWIRE) — Progress (Nasdaq: PRGS), the trusted provider of infrastructure software, today announced financial results for its fiscal first quarter ended February 28, 2023. First Quarter 2023 Highlights1:Revenue of $164.2 million increased 13% year-over-year on an actual currency basis, and 15% on a constant currency basis. Non-GAAP revenue of $165.6 million increased 12% year-over-year on an actual currency basis, and increased 14% on a constant currency basis. Annualized Recurring Revenue (“ARR”) of $569 million increased 20% year-over-year on a constant currency basis. Operating margin was 22% and Non-GAAP operating margin was 44%. Diluted earnings per share was $0.53 compared to $0.46...

Omega Flex, Inc. Announces Regular Quarterly Dividend for the First Quarter 2023

Written by Customer Service on March 28, 2023. Posted in Dividend Reports And Estimates.

EXTON, Pa., March 28, 2023 (GLOBE NEWSWIRE) — Omega Flex, Inc. (the “Company”) (NASDAQ: OFLX) today announced that the Board of Directors declared a regular quarterly dividend of $0.32 per share payable on April 24, 2023, to shareholders of record on April 10, 2023. In determining the amount of future regular quarterly dividends, the Board will review the cash needs of the Company, and based on results of operations, financial condition, capital expenditure plans, and consideration of possible acquisitions, as well as such other factors as the Board of Directors may consider relevant, determine on a quarterly basis the amount of a regular quarterly dividend. This news release contains forward-looking statements, which are subject to inherent uncertainties which are difficult to predict and may be beyond the ability of our control. Certain...

ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights

Written by Customer Service on March 28, 2023. Posted in Earnings Releases And Operating Results.

WINSTON-SALEM, N.C., March 28, 2023 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced financial results for the fourth quarter ended December 31, 2022, and provided an update on recent corporate developments. “Throughout 2022, we made great progress in our mission to develop and provide a treatment with the potential to preserve kidney function in patients with late-stage CKD who are at high risk for kidney failure,” said Dr. Tim Bertram, Chief Executive Officer of ProKidney. “The first of two pivotal Phase 3 trials of REACT® is progressing with enrollment, as are several ongoing Phase 2 clinical studies, while the second Phase 3 trial continues to advance toward enrollment. Moreover,...

Micron Technology, Inc. Reports Results for the Second Quarter of Fiscal 2023

Written by Customer Service on March 28, 2023. Posted in Earnings Releases And Operating Results.

Achieving technology milestones while cutting expenses and reducing supply BOISE, Idaho, March 28, 2023 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) today announced results for its second quarter of fiscal 2023, which ended March 2, 2023. Fiscal Q2 2023 highlightsRevenue of $3.69 billion versus $4.09 billion for the prior quarter and $7.79 billion for the same period last year GAAP net loss of $2.31 billion, or $2.12 per diluted share Non-GAAP net loss of $2.08 billion, or $1.91 per diluted share Inventory write-downs of $1.43 billion, impact of $1.34 per diluted share Operating cash flow of $343 million versus $943 million for the prior quarter and $3.63 billion for the same period last year“Micron delivered fiscal second quarter revenue within our guidance range in a challenging market environment,” said Micron...

Gulf Island Reports Fourth Quarter and Full-Year 2022 Results

Written by Customer Service on March 28, 2023. Posted in Earnings Releases And Operating Results.

THE WOODLANDS, Texas , March 28, 2023 (GLOBE NEWSWIRE) — Gulf Island Fabrication, Inc. (NASDAQ: GIFI) (“Gulf Island” or the “Company”), a leading steel fabricator and service provider to the industrial and energy sectors, today announced results for the fourth quarter and full-year 2022. FOURTH QUARTER 2022 SUMMARY (as compared to the fourth quarter 2021)Revenue of $38.1 million, 47.8% increase y/y Consolidated income from continuing operations and EBITDA of $0.5 million and $1.7 million, respectively, each including a loss of $3.6 million for the Shipyard Division and net gains of $3.0 million from insurance recoveries Services Division operating income and EBITDA of $2.2 million and $2.6 million, respectively Fabrication Division operating income and EBITDA of $4.1 million and $5.0 million, respectively, each including net...

Hallmark Announces Fourth Quarter and Fiscal 2022 Results

Written by Customer Service on March 28, 2023. Posted in Earnings Releases And Operating Results.

Hallmark Financial Services, Inc. Hallmark Financial Services, Inc.DALLAS, March 28, 2023 (GLOBE NEWSWIRE) — Hallmark Financial Services, Inc. (“Hallmark”) (NASDAQ: HALL) today filed its Form 10-K and announced financial results for the fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter Year-to-Date 2022 2021 2022 2021$ in millions: Net loss from continuing operations $ (30.0 ) $ (5.9 ) $ (134.9 ) $ (9.8 )Net income from discontinued operations $ 22.7 $ 3.3 $ 26.8 $ 18.8 Net (loss) income $ (7.3 ) $ (2.6 ) $ (108.1 ) $ 9.0 Operating loss (1) $ (30.3 ) $ (6.8 ) $ (99.6 ) $ (17.9 ) $ per diluted share (2): Net loss from continuing operations $ (16.48 ) $ (3.26 ) $ (74.22 ) $ (5.38 )Net income from discontinued operations $ 12.46 $ 1.84 $ 14.75 $ 10.34 Net...

Shift Announces Fourth Quarter Results

Written by Customer Service on March 28, 2023. Posted in Earnings Releases And Operating Results.

Sold 2,520 retail units and achieved $65.6 million in revenue Successfully closed the merger with CarLotz and transitioned to omnichannel selling model Regained compliance with Nasdaq Stock Market minimum bid price requirementSAN FRANCISCO, March 28, 2023 (GLOBE NEWSWIRE) — Shift Technologies, Inc. (Nasdaq: SFT), a leading end-to-end ecommerce platform for buying and selling used cars, today reported fourth quarter financial results for the period ended December 31, 2022. Management’s commentary on fourth quarter financial results and outlook for the first quarter 2023 can be found by accessing the Company’s prepared remarks on investors.shift.com, or by listening to today’s conference call. A live audio webcast will also be available on Shift’s Investor Relations website. “2022 was a year of significant change for Shift,” said...

Vincerx Pharma Reports Fourth Quarter and Full Year 2022 Financial Results and Provides a Corporate Update

Written by Customer Service on March 28, 2023. Posted in Earnings Releases And Operating Results.

First cohort dosed in Phase 1 first-in-human dose-escalation study of VIP236, an αvβ3 small molecule drug conjugate (SMDC) in advanced solid tumors IND filing for antibody drug conjugate (ADC) VIP943 remains on track for mid-2023; expected to be in clinic in the second half 2023 Anticipate dosing first patient in Phase 1b combination study of enitociclib and approved Bruton tyrosine kinase (BTK) inhibitor in CLL in second quarter 2023 Expected cash runway into late 2024 PALO ALTO, Calif., March 28, 2023 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today reported financial results for the fourth quarter and full year ended December 31, 2022, and provided a corporate update. “Vincerx made...

Day: March 28, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals